KEMSA GF ATM HIV GC7/OIT 03/2026-2027: Supply of ARVs Adult Medicines II (open tender, closes 27 Oct 2026)

What is being bought

Kenya Medical Supplies Authority (KEMSA) is tendering for the supply of antiretroviral (ARV) adult medicines under reference GF ATM HIV GC7/OIT 03/2026-2027, divided into 5 items or lots. Delivery is DAP to the KEMSA warehouse in Nairobi, Kenya, per the tender data sheet. Quantities are not stated in the reviewed pages.

Key facts

Closing

Tue 27 Oct 2026, 10:00 am
Tender closes 27 October 2026 at 10:00 a.m. local time at KEMSA, Embakasi, Nairobi. Portal closing time matches. D2 p.30

Bid / tender security

Tender security of USD 400,000.00 or KES 51,600,000.00 or equivalent in freely convertible currency, valid for 240 days from tender opening; original required; electronic tender securities acceptable, authenticated by QR scanner. D2 p.31

Tender fee

Not stated in the documents we reviewed Not stated D2

Site visit

Not stated in the documents we reviewed Not stated D2

Pre-bid meeting

Optional
No pre-bid meeting is stated in the reviewed material. Clarification requests must reach KEMSA by 20 October 2026. D2 p.29

Reserved for

No reservation to a specific group (SME, women, youth, persons with disability) is stated for this tender; the tender is open to all interested tenderers. P

Contract value

Not stated in the documents we reviewed Not stated D2

Tender opening

Tender opening at the Tender Opening/Conference Hall, KEMSA National Supply Chain Centre, Embakasi Off Airport North Road, Nairobi, on the closing date and time. D2 p.30

Tender validity

Tender validity period is 210 days. D2 p.30

Who can apply

• Open tender: the reviewed pages do not restrict eligibility to a reserved group. Tenderers must meet the eligibility requirements in ITT 4 and have no conflict of interest. D2 p.1

Application checklist

Tick items off as you prepare. Your ticks stay on this device only.

Required from every bidder

• Tender security (bid security) as stated in bid_security item, valid for 240 days from tender opening, in original form. D2 p.39
• Paginated documents: all pages numbered in continuous ascending order (1, 2, 3 ... n). D2 p.39
• Certificate of Incorporation or Registration (copy). D2 p.39
• Tender form on letterhead showing the tenderer's complete name and business address, duly completed and signed (power of attorney attached where applicable). D2 p.39
• Tenderer's Eligibility Confidential Business Questionnaire, completed and signed. D2 p.39
• Certificate of Independent Tender Determination, completed and signed. D2 p.39
• Self-declarations, each signed: not debarred under PPADA 2015; will not engage in corrupt or fraudulent practice; declaration and commitment to the code of ethics. D2 p.39
• WHO prequalification reference number and/or proof of listing by a WHO Listed Authority (WLA), and tentative approval reference number, in the technical tender. D2 p.38
• Current and valid Good Manufacturing Practice (GMP) certificate from an independent regulatory authority. D2 p.39
• Pharmacy and Poisons Board of Kenya: product registration certificate (if registered within the year) or valid Product Retention Certificate with QR codes (if registered in prior years). D2 p.39
• Current and valid Manufacturing License. D2 p.39
• Product samples for evaluation under separate cover, at or before the closing date and time, clearly labelled with tenderer name, tender reference and product, representing exactly the product to be supplied; a certificate of analysis from the manufacturer's lab for the same batch is required on award. D2 p.30
• Products must be WHO prequalified and/or authorised by a Stringent Regulatory Authority (SRA) under the Global Fund Quality Assurance Policy, and manufactured to a recognised pharmacopoeia monograph (International, British, US, European, or manufacturer specifications). D2 p.30

Required only in some situations

• Valid and current Tax Compliance Certificate (copy), mandatory for local bidders. D2 p.39
• Manufacturer's Authorization on manufacturer's letterhead, addressed to KEMSA, tender and item specific, signed by an authorised signatory (applies to bidders who are not manufacturers). D2 p.38
• Current wholesale dealer's licence with QR codes from the Pharmacy and Poisons Board of Kenya, applicable to local bidders. D2 p.40
• Current Superintendent Pharmacist practising licence with QR codes from the Pharmacy and Poisons Board of Kenya, applicable to local bidders. D2 p.40

Experience, licences and financial capacity

Technical

• Goods must be registered with the Pharmacy and Poisons Board of Kenya. Contact for registration information: the Chief Executive Officer. D2 p.30
• Experience: at least 3 similar supply contracts completed or substantially completed within the last three years; similar means approximately the same size and comparable products. D2 p.38
• Annual production rate at least three times the quantities specified under the contract (manufacturer statement). D2 p.41
• Certificate of Origin required for all import consignments into Kenya. D2 p.81
• Delivery: DAP, named place of destination KEMSA Warehouse, Nairobi, Kenya; Incoterms 2020; prices to a maximum of two decimal points. D2 p.30

Financial

• Post-qualification (if no prequalification): maximum of 3 supply contracts for Health Products within the past 3 years equal to the contract sum, one at least 60% of the tender sum. D2 p.40
• Average annual turnover over the last three years equal to the tender sum, supported by certified financial statements for the past three years. D2 p.41
• Minimum turnover and cash-flow amounts in the post-qualification section are blank in the reviewed pages; the amounts are not stated. Not stated D2 p.36

How and where to submit

• Submit in writing (physical hard copy). Electronic submission is not allowed. Original tender plus 1 copy; power of attorney for signatory. D2 p.30
• Deliver to The Chief Executive Officer, KEMSA, National Supply Chain Centre, Embakasi Off Airport North Road, P.O. Box 47715-00100, Nairobi, Kenya. Tel +254111035800; procurement.program@kemsa.go.ke. D2 p.30
• Original tender plus 1 copy (In addition to the original of the tender, the number of copies is 1 (One)). D2 p.31
• Authorisation to sign for the tenderer: a written Power of Attorney. D2 p.31

Lots and categories

• Lot 5 lots: Five items/lots comprise this tender. Tenderers may bid for individual lots; contract may be awarded across lots per the evaluation option selected by the procuring entity (not yet selected in the reviewed text). D2 p.29

What the addenda changed

• No addenda were provided in the reviewed material. Not stated P

Not covered in the documents we reviewed

• Quantities per item/lot and the delivery schedule (Section V Schedule of Requirements pages 83-87).
• Post-qualification amounts for minimum turnover, cash flow and contract value (blank in D2 p.36).
• Tender document fee, if any, and how to pay it.
• Full ITT 19 and 20 text beyond the TDS, and the tender opening and submission details in the standard forms.
• Section VIII/IX special conditions (payment terms, delivery penalties, performance security).
• Forms for tender security (pages 71-74) and the form of tender pricing schedules.
• Any addenda after the original tender document.
• Site visit or pre-bid meeting details, if any.

Terms explained

ARVs

Antiretroviral medicines used to treat HIV.

Tender Data Sheet (TDS)

The section of the tender document that gives the specific rules for this tender and overrides the general instructions.

Tender security (bid security)

A guarantee submitted with the bid to protect the buyer if the bidder withdraws or fails to sign.

DAP

Delivered at Place (Incoterms 2020): seller delivers to the named place, buyer handles import clearance and unloading.

WHO prequalification / WLA

Approval by the World Health Organization or a WHO Listed Authority that a medicine meets quality standards.

Manufacturer's Authorization

A letter from the manufacturer authorising a non-manufacturer to supply its product for this tender.

Responsive

A bid that meets all mandatory requirements of the tender documents; non-responsive bids are rejected.

Power of Attorney

A written document authorising a named person to sign the tender on the company's behalf.

Certificate of Independent Tender Determination

A signed form confirming the bid was prepared without collusion with other bidders.